Akero Therapeutics | S-3ASR:“知名成熟发行人”证券注册声明
Akero Therapeutics | 10-Q:季度报表
Akero Therapeutics | 8-K:Akero Therapeutics公布2024年第一季度财务业绩并提供业务最新情况
Akero Therapeutics | 4:持股变动声明-高管 Young Jonathan
Akero Therapeutics | 4:持股变动声明-高管 Gangloff Scott A.
Akero Therapeutics | 3:首次持股声明-高管 Gangloff Scott A.
Akero Therapeutics | ARS:年度报告
Akero Therapeutics | DEF 14A:股东委托书决议
Akero Therapeutics | PRE 14A:并购重组委托声明
Akero Therapeutics | 4:持股变动声明-高管 Young Jonathan
Akero Therapeutics | 144:拟议出售证券
Akero Therapeutics | 8-K:重大事件
Akero Therapeutics | 4:持股变动声明-高管 Yale Catriona
Akero Therapeutics | 4:持股变动声明-高管 White William Richard
Akero Therapeutics | 4:持股变动声明-高管 Cheng Andrew
Akero Therapeutics | 4:持股变动声明-高管 Rolph Timothy
Akero Therapeutics | 4:持股变动声明-高管 Young Jonathan
Akero Therapeutics | SC 13G:超过5%持股股东披露文件-General Atlantic, L.P.(7.7%),General Atlantic Partners 100, L.P.(7.7%)等
Akero Therapeutics | 4:持股变动声明-高管 Cheng Andrew
Akero Therapeutics | 4:持股变动声明-高管 Yale Catriona
暂无数据